🇺🇸 FDA
Pipeline program

FLUOROURACIL , OXALIPLATIN , GEMCITABINE , FOLIC ACID

D20180177

Phase 3 small_molecule active

Quick answer

FLUOROURACIL , OXALIPLATIN , GEMCITABINE , FOLIC ACID for Pancreatic adenocarcinoma (PAC) is a Phase 3 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Pari Pharma GmbH
Indication
Pancreatic adenocarcinoma (PAC)
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials